Related Experiment Video
Updated: Mar 16, 2026

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
[AFFINOLEUKINE IS AN IMMUNOTHERAPEUTIC ADJUVANT IN THE TREATMENT OF PULMONARY TUBERCULOSIS IN ADOLESCENTS]
Abstract:
The clinical and immunological efficacy of the immunotherapeutic drug affinoleukine (AFL) in the treatment of pulmonary tuberculosis was studied in adolescents. Examination of patients who had mainly infiltrative pulmonary tuberculosis in the randomized study and control groups (23 subjects in each group) showed the good clinical tolerability of the drug and the signs of more effective resolution of infiltrative changes in the study group. An immunological study of the patients receiving AFL ascertained the higher specific antigen-induced production of interferon-γ (IFN-γ) in the whole blood samples in vitro; immunophenotyping showed a higher percentage of circulating gamma/delta T lymphocytes and a lower proportion of a subpopulation of IFN-γ-producing gamma/delta T lymphocytes, including in vitro antigen-induced ones. It is assumed that AFL increases the migration of effector gamma/delta cells to the foci of tuberculous inflammation.
More Related Videos
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
15:57Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle
Published on: July 11, 2015
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...